Does FDG-PET add information to EUS and CT in the initial management of esophageal cancer? A prospective single center study
- PMID: 17941963
- DOI: 10.1111/j.1572-0241.2007.01579.x
Does FDG-PET add information to EUS and CT in the initial management of esophageal cancer? A prospective single center study
Abstract
Purpose: There is no algorithm for the initial staging of esophageal cancer that is considered standard of care. This prospective blinded study analyzes the utility of FDG-PET as an adjunct to EUS and CT for the management of patients with esophageal cancer.
Methods: Between December 2003 and October 2006, patients diagnosed with esophageal carcinoma underwent EUS, CT, and FDG-PET at their initial evaluation. Two thoracic surgeons were given staging EUS results and CT scan reports. They were asked if the patient needed surgical resection, neoadjuvant chemotherapy followed by resection, or palliation. With each case, one surgeon was unblinded to the FDG-PET results. The treatment decisions of each surgeon were compared to determine if PET altered clinical management.
Results: A total of 50 patients (45 male, 5 female) were enrolled and data were prospectively collected. Forty-three (86%) had adenocarcinoma and 7 (14%) had squamous cell carcinoma. EUS was completed in 88% (44) of cases while 6 (12%) were incomplete secondary to tight stenosis. Nineteen were treated with surgery, 25 with neoadjuvant chemotherapy and surgery, and 6 with palliative chemoradiation. In 49 of 50 patients, the surgeons came to identical management decisions independent of PET results. In the one case that the treatment decision differed, the EUS was incomplete. The agreement on treatment strategy was 98% (kappa= 0.97, 95% CI 0.93-0.99).
Conclusion: This study shows that the addition of FDG-PET to EUS and CT offers little information to the initial treatment stratification of patients with esophageal cancer. However, in patients with incomplete EUS, FDG-PET may have some clinical utility.
Similar articles
-
The accuracy of endoscopic ultrasonography with fine-needle aspiration, integrated positron emission tomography with computed tomography, and computed tomography in restaging patients with esophageal cancer after neoadjuvant chemoradiotherapy.J Thorac Cardiovasc Surg. 2005 Jun;129(6):1232-41. doi: 10.1016/j.jtcvs.2004.12.042. J Thorac Cardiovasc Surg. 2005. PMID: 15942562
-
The role and clinical value of EUS in a multimodality esophageal carcinoma staging program with CT and positron emission tomography.Gastrointest Endosc. 2007 Mar;65(3):377-84. doi: 10.1016/j.gie.2006.12.015. Gastrointest Endosc. 2007. PMID: 17321235 Clinical Trial.
-
Response monitoring of neoadjuvant therapy using CT, EUS, and FDG-PET.Best Pract Res Clin Gastroenterol. 2006;20(5):941-57. doi: 10.1016/j.bpg.2006.04.004. Best Pract Res Clin Gastroenterol. 2006. PMID: 16997171 Review.
-
The utility of positron emission tomography for the diagnosis and staging of recurrent esophageal cancer.J Thorac Cardiovasc Surg. 2000 Dec;120(6):1085-92. doi: 10.1067/mtc.2000.110464. J Thorac Cardiovasc Surg. 2000. PMID: 11088030
-
Staging in oesophageal cancer.Best Pract Res Clin Gastroenterol. 2006;20(5):877-91. doi: 10.1016/j.bpg.2006.05.001. Best Pract Res Clin Gastroenterol. 2006. PMID: 16997167 Review.
Cited by
-
A propensity-matched analysis comparing survival after primary minimally invasive esophagectomy followed by adjuvant therapy to neoadjuvant therapy for esophagogastric adenocarcinoma.J Thorac Cardiovasc Surg. 2015 Feb;149(2):538-47. doi: 10.1016/j.jtcvs.2014.10.044. Epub 2014 Oct 14. J Thorac Cardiovasc Surg. 2015. PMID: 25454907 Free PMC article.
-
A 18F-FDG PET/CT-based deep learning-radiomics-clinical model for prediction of cervical lymph node metastasis in esophageal squamous cell carcinoma.Cancer Imaging. 2024 Nov 12;24(1):153. doi: 10.1186/s40644-024-00799-0. Cancer Imaging. 2024. PMID: 39533388 Free PMC article.
-
Use of endoscopic ultrasound in pre-treatment staging of esophageal cancer did not alter management plan.J Thorac Dis. 2020 Oct;12(10):5850-5856. doi: 10.21037/jtd-20-1299. J Thorac Dis. 2020. PMID: 33209417 Free PMC article.
-
The early use of PET-CT alters the management of patients with esophageal cancer.J Gastrointest Surg. 2009 May;13(5):868-73. doi: 10.1007/s11605-009-0812-z. Epub 2009 Jan 28. J Gastrointest Surg. 2009. PMID: 19184245 Clinical Trial.
-
Oesophageal cancer: can imaging improve its assessment?Eur J Nucl Med Mol Imaging. 2008 Oct;35(10):1921-7. doi: 10.1007/s00259-008-0884-0. Eur J Nucl Med Mol Imaging. 2008. PMID: 18682938 No abstract available.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical